However, there was no significant difference in doxorubicin sensitivity between CK7-positive (average rank 36.29) and CK7-negative (average rank 30.16) liver cancer cells (W = 754.000, Z = −1.603, P=0.109). This evidence concerns the gene KRT7 and liver cancer.